Larvol Delta - Convergent-Therapeutics-to-Present-Largest-Set-of-Prospective-Phase-2-Data-for-an-Alpha-Radiopharmaceutical-in-LuPSMAExposed-Metastatic-CastrationResistant-Prostate-Cancer-at-ASCO-2026

Ac-225 rosopatamab tetraxetan (CONV01-α) - Convergent Therapeutics

https://www.businesswire.com/news/home/20260521939719/en/Convergent-Therapeutics-to-Present-Largest-Set-of-Prospective-Phase-2-Data-for-an-Alpha-Radiopharmaceutical-in-Lu-PSMA-Exposed-Metastatic-Castration-Resistant-Prostate-Cancer-at-ASCO-2026

May 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next